Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
4.660
-0.140 (-2.92%)
At close: Nov 20, 2024, 4:00 PM
4.770
+0.110 (2.36%)
After-hours: Nov 20, 2024, 7:57 PM EST
Relay Therapeutics Employees
Relay Therapeutics had 323 employees as of December 31, 2023. The number of employees decreased by 4 or -1.22% compared to the previous year.
Employees
323
Change (1Y)
-4
Growth (1Y)
-1.22%
Revenue / Employee
$30,978
Profits / Employee
-$1,068,728
Market Cap
780.00M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 323 | -4 | -1.22% |
Dec 31, 2022 | 327 | 82 | 33.47% |
Dec 31, 2021 | 245 | 86 | 54.09% |
Dec 31, 2020 | 159 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Avanos Medical | 3,771 |
Embecta | 2,200 |
Pacira BioSciences | 712 |
Cytek Biosciences | 676 |
AbCellera Biologics | 586 |
Cronos Group | 356 |
Prothena Corporation | 173 |
Pliant Therapeutics | 158 |
RLAY News
- 14 days ago - Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights - GlobeNewsWire
- 21 days ago - Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024 - GlobeNewsWire
- 2 months ago - Relay Therapeutics: 2nd-Line RLY-2608 Data Moves Program Towards Expansion - Seeking Alpha
- 2 months ago - Relay Therapeutics' RLY-2608 Shows Promise For Breast Cancer With PI3Kα Mutations - Seeking Alpha
- 2 months ago - GameStop Reports Weak Sales, Joins Petco, Relay Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 2 months ago - Relay Therapeutics Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market - Benzinga
- 2 months ago - This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga